Holen Sie sich die Stockscreener-App
19.75
0.80%
0.1512
Schlusskurs vom Vortag:
$19.60
Offen:
$19.325
24-Stunden-Volumen:
7.14M
Relative Volume:
0.96
Marktkapitalisierung:
$13.48B
Einnahmen:
$125.68M
Nettoeinkommen (Verlust:
$4.81B
KGV:
3.4958
EPS:
5.65
Netto-Cashflow:
$-781.21M
1W Leistung:
+7.31%
1M Leistung:
+22.18%
6M Leistung:
+72.09%
1J Leistung:
+71.35%
1-Tages-Spanne:
$19.32
$19.79
1-Wochen-Bereich:
$18.32
$20.09
52-Wochen-Spanne:
$8.73
$20.09
Roivant Sciences Ltd Stock (ROIV) Company Profile
Firmenname
Roivant Sciences Ltd
Sektor
Branche
Telefon
441-295-5950
Adresse
7TH FLOOR, 50 BROADWAY, LONDON
Vergleichen Sie ROIV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
19.75 | 13.38B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.93 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.29 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.56 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
838.57 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-02 | Eingeleitet | Citigroup | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-01-05 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Eingeleitet | Guggenheim | Buy |
| 2023-06-08 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-27 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Eingeleitet | Goldman | Buy |
| 2021-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-28 | Eingeleitet | Citigroup | Buy |
| 2021-10-26 | Eingeleitet | Cowen | Outperform |
| 2021-10-26 | Eingeleitet | Jefferies | Buy |
| 2021-10-26 | Eingeleitet | Truist | Buy |
Alle ansehen
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Roivant Sciences (ROIV) Projected to Post Earnings on Monday - MarketBeat
Hantz Financial Services Inc. Increases Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Do You Believe in the Growth Prospects of Roivant Sciences Ltd. (ROIV)? - Yahoo Finance
Will Roivant Sciences Ltd. stock reach Wall Street targets2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsPortfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
22,600 Shares in Roivant Sciences Ltd. $ROIV Purchased by IFG Advisory LLC - MarketBeat
How to forecast Roivant Sciences Ltd. trends using time seriesGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
Will Roivant Sciences Ltd. stock gain from government policiesMarket Movement Recap & Real-Time Buy Zone Alerts - newser.com
Is Roivant Sciences Ltd. (87S) stock a contrarian opportunityJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
Is Roivant Sciences Ltd. stock recession proof2025 Price Momentum & Weekly High Potential Alerts - newser.com
Best data tools to analyze Roivant Sciences Ltd. stockJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
How to read the order book for Roivant Sciences Ltd.Weekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
Chart based exit strategy for Roivant Sciences Ltd.Weekly Risk Report & Accurate Technical Buy Alerts - newser.com
Top chart patterns to watch in Roivant Sciences Ltd.Dividend Hike & Daily Chart Pattern Signal Reports - newser.com
Why Roivant Sciences Ltd. (87S) stock attracts wealthy investorsFed Meeting & Advanced Technical Analysis Signals - newser.com
Is Roivant Sciences Ltd. (87S) stock prepared for digital transitionIndex Update & Safe Entry Zone Tips - newser.com
Pier Capital LLC Reduces Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Hits New 52-Week High of $19.66, Up 85% - Markets Mojo
Transcend Capital Advisors LLC Purchases New Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
Roivant Sciences stock hits all-time high at 18.95 USD By Investing.com - Investing.com Australia
Roivant Sciences Ltd. stock prediction for this weekMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Key metrics from Roivant Sciences Ltd.’s quarterly data2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Can Roivant Sciences Ltd. rally from current levelsPortfolio Gains Summary & Safe Entry Zone Identification - newser.com
Can Roivant Sciences Ltd. (87S) stock double in coming yearsJuly 2025 Update & Consistent Profit Alerts - newser.com
Risk vs reward if holding onto Roivant Sciences Ltd.2025 Top Gainers & Verified Entry Point Signals - newser.com
Roivant Sciences stock hits all-time high at 18.95 USD - Investing.com
Will Roivant Sciences Ltd. (87S) stock outperform benchmarksBuy Signal & Weekly Setup with ROI Potential - newser.com
Y Intercept Hong Kong Ltd Acquires Shares of 271,903 Roivant Sciences Ltd. $ROIV - MarketBeat
Citigroup Raises Price Target for ROIV, Maintains Buy Rating | R - GuruFocus
Roivant Sciences (ROIV): Evaluating Valuation After Strong Share Price Momentum in Biotech - Yahoo Finance
Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $25 - 富途牛牛
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):